Search results for: “diet “


  • Efficacy of Personalized Nutrition Based on Gut Microbiome and Clinical Data in Prediabetes

    Eran Segal, PhD, previews his presentation “Efficacy of Personalized Nutrition Based on Gut Microbiome and Clinical Data in Prediabetes,” which begins at 11:40 a.m. CT Saturday, June 13.


  • Professional Interest Group Discussion on Nutritional Science and Metabolism—Emerging Methodologies for Personalized Nutrition—Potential Effects on Glycemic and Other Diabetes-Related Outcomes?

    Guoxun Chen, PhD, previews his response and discussion from the Professional Interest Group Discussion “Nutritional Science and Metabolism—Emerging Methodologies for Personalized Nutrition—Potential Effects on Glycemic and Other Diabetes-Related Outcomes?” The session begins at 11:30 a.m. CT Saturday, June 13. Dr. Chen’s presentation will begin at 12:10 p.m. CT.


  • Manipulating the Gut Microbiome to Treat Diabetes

    Emma E. Hamilton-Williams, PhD, describes results from the TOGeTHER Trial of type 1 diabetes patients, who were treated with a specially modified dietary fiber designed to deliver short-chain fatty acids into the large intestine. Her presentation details the impact of the supplement on the gut bacteria and diabetes management of the participants, revealing a promising…


  • Low-Carbohydrate Diets and Nutritional Ketosis

    Jessica L. Turton, APD, BAppSc (Ex&SpSc), MNutriDiet, previews her presentation “Low-Carbohydrate Diets and Nutritional Ketosis,” which begins at 2:30 p.m. CT Friday, June 12.


  • A New Era—Leveraging RDNs in Medication Management in Reducing Therapeutic Inertia

    Gretchen Benson, RDN, CDCES, discussed how a team-based approach featuring an expanded role for registered dietitian nutritionists (RDN) can help patients with type 2 diabetes, hypertension, and hyperlipidemia achieve better outcomes. She highlighted results from several studies demonstrating the benefits of expanding the role of RDNs in initiating/titrating medications.


  • Scientific Sessions include four days of virtual networking opportunities for ADA members

    ADA’s Interest Group Leadership Teams have been hard at work planning virtual networking events, which will allow members to linger virtually at the back of the lecture hall discussing new research, share perspectives on a variety of hot topics in diabetes, and contribute to the future planning of ADA’s Interest Group activities.


  • TEDDY Study providing insight into the type 1 diabetes disease process in children

    A panel of investigators, including Beena Akolkar, PhD, will present recent findings from the ongoing TEDDY Study during the Scientific Sessions. TEDDY is a multi-center study funded by the NIDDK designed to investigate the etiology of type 1 diabetes and identify environmental triggers of the disease.


  • With very few exceptions, Virtual 80th Scientific Sessions will feature entire program planned before COVID-19

    On Friday, April 3, the global COVID-19 (coronavirus) pandemic forced the ADA to restructure its flagship professional event from an in-person meeting to a virtual experience to be held over the same dates, June 12-16, 2020. What won’t change, according to Jose C. Florez, MD, PhD, Chair of the 80th Scientific Sessions Meeting Planning Committee,…


  • PREVIEW study results show diet, weight management can delay type 2 diabetes progression in prediabetes patients

    Results from the PREVIEW study, which compared the benefits of two diet and two weight management programs, showed comparable rates of delay toward type 2 diabetes development in patients with prediabetes who had initially lost weight on a low-calorie diet, according to Ian MacDonald, BSc, PhD.


  • Experts discuss mealtime and monitoring tips for parents of pediatric type 1 diabetes patients

    During a Monday morning symposium at the Scientific Sessions, a panel of pediatric diabetes experts, including Nana-Hawa Yayah Jones, MD, discussed the challenges parents and providers face when trying to manage the dietary and nutritional needs of children with type 1 diabetes.